IRIS Accounts Production v23.2.0.158 11867988 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure118679882022-03-31118679882023-03-31118679882022-04-012023-03-31118679882021-03-31118679882021-04-012022-03-31118679882022-03-3111867988ns16:EnglandWales2022-04-012023-03-3111867988ns15:PoundSterling2022-04-012023-03-3111867988ns11:Director12022-04-012023-03-3111867988ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3111867988ns11:SmallEntities2022-04-012023-03-3111867988ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3111867988ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111867988ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111867988ns11:FullAccounts2022-04-012023-03-3111867988ns11:OrdinaryShareClass12022-04-012023-03-3111867988ns11:OrdinaryShareClass22022-04-012023-03-3111867988ns6:CurrentFinancialInstruments2023-03-3111867988ns6:CurrentFinancialInstruments2022-03-3111867988ns6:ShareCapital2023-03-3111867988ns6:ShareCapital2022-03-3111867988ns6:RetainedEarningsAccumulatedLosses2023-03-3111867988ns6:RetainedEarningsAccumulatedLosses2022-03-3111867988ns11:RegisteredOffice2022-04-012023-03-3111867988ns6:PlantMachinery2022-03-3111867988ns6:ComputerEquipment2022-03-3111867988ns6:PlantMachinery2022-04-012023-03-3111867988ns6:ComputerEquipment2022-04-012023-03-3111867988ns6:PlantMachinery2023-03-3111867988ns6:ComputerEquipment2023-03-3111867988ns6:PlantMachinery2022-03-3111867988ns6:ComputerEquipment2022-03-3111867988ns11:OrdinaryShareClass12023-03-3111867988ns11:OrdinaryShareClass22023-03-3111867988ns11:Director112022-03-3111867988ns11:Director112021-03-3111867988ns11:Director112022-04-012023-03-3111867988ns11:Director112021-04-012022-03-3111867988ns11:Director112023-03-3111867988ns11:Director112022-03-31
REGISTERED NUMBER: 11867988 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st March 2023

for

Elite Cardiac Screening Ltd

Elite Cardiac Screening Ltd (Registered number: 11867988)






Contents of the Financial Statements
for the Year Ended 31st March 2023




Page

Statement of Financial Position 1

Notes to the Financial Statements 2


Elite Cardiac Screening Ltd (Registered number: 11867988)

Statement of Financial Position
31st March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 27,326 37,250

CURRENT ASSETS
Debtors 5 - 1,950
Cash at bank 390,906 233,367
390,906 235,317
CREDITORS
Amounts falling due within one year 6 54,236 32,756
NET CURRENT ASSETS 336,670 202,561
TOTAL ASSETS LESS CURRENT
LIABILITIES

363,996

239,811

PROVISIONS FOR LIABILITIES 5,388 7,166
NET ASSETS 358,608 232,645

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 358,606 232,643
SHAREHOLDERS' FUNDS 358,608 232,645

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15th November 2023 and were signed on its behalf by:





Dr D Rakhit - Director


Elite Cardiac Screening Ltd (Registered number: 11867988)

Notes to the Financial Statements
for the Year Ended 31st March 2023

1. COMPANY INFORMATION

Elite Cardiac Screening Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11867988

Registered office: Bramber House
59 Lakewood Road
Hiltingbury
Chandlers Ford
Hampshire
SO53 1EU

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or
valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual
values over their useful lives on the following basis:

Computer Equipment - 20% on cost
Plant and Machinery - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the
sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Elite Cardiac Screening Ltd (Registered number: 11867988)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1st April 2022 43,962 9,043 53,005
Additions - 3,433 3,433
At 31st March 2023 43,962 12,476 56,438
DEPRECIATION
At 1st April 2022 12,645 3,110 15,755
Charge for year 10,990 2,367 13,357
At 31st March 2023 23,635 5,477 29,112
NET BOOK VALUE
At 31st March 2023 20,327 6,999 27,326
At 31st March 2022 31,317 5,933 37,250

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors - 1,950

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Tax 31,299 24,863
Directors' current accounts 20,408 5,629
Accrued expenses 2,529 2,264
54,236 32,756

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
2 2

The Ordinary A shares rank equally in terms of voting rights, rights to participate in all dividend
distributions and rights to participate in any capital distribution on winding up.

The Ordinary B shares do not hold any voting rights and dividend rights are at the discretion of the
Ordinary A shareholders.

The A and B shares rank pari passu in respect of dividend and capital distribution rights.

Elite Cardiac Screening Ltd (Registered number: 11867988)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2023

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2023 and 31st March 2022:

31.3.23 31.3.22
£    £   
Dr D Rakhit
Balance outstanding at start of year (5,629 ) (3,020 )
Amounts repaid (14,779 ) (2,609 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (20,408 ) (5,629 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr Rakhit by virtue of holding 100% of the voting share capital.